AG
EPZM

Algert Global’s Epizyme, Inc EPZM Stock Holding History

Algert Global’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-54,360
Closed -$136K – 1360
2021
Q4 		$136K Buy
+54,360
New +$214K 0.02% 895
2020
Q2 		– Sell
-24,968
Closed -$387K – 527
2020
Q1 		$387K Sell
24,968
-20,206
-45% -$434K 0.16% 207
2019
Q4 		$1.11M Sell
45,174
-39,830
-47% -$591K 0.33% 111
2019
Q3 		$877K Sell
85,004
-23,192
-21% -$293K 0.33% 106
2019
Q2 		$1.36M Buy
+108,196
New +$1.39M 0.5% 67

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Algert Global's EPZM Position: Q1 2022 in Review

Algert Global sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 54,360 shares — an estimated $136K sold.

Algert Global first reported a position in EPZM in Q2 2019 and held it in 5 quarters. The position peaked at $1.36M in Q2 2019. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • Algert Global reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
  • Algert Global sold 54,360 Epizyme, Inc shares in Q1 2022, an estimated $136K.
  • Algert Global first reported a position in Epizyme, Inc in Q2 2019 and held it in 5 quarters.
  • Algert Global's Epizyme, Inc position peaked at $1.36M in Q2 2019.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on Algert Global's 13F filing for Q1 2022, filed 16 May 2022.